Lyme Carditis

Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Infectious Disease Clinics of North America (Impact Factor: 2.73). 07/2008; 22(2):275-88, vi. DOI: 10.1016/j.idc.2007.12.008
Source: PubMed

ABSTRACT Cardiovascular manifestations of Lyme disease were first reported nearly 30 years ago. This article describes Lyme carditis, its epidemiology, pathophysiology, methods of diagnosis, and treatment options.

14 Reads
  • Source
    • "Lyme carditis typically occurs during the early disseminated phase (weeks to months) after a Borrelia burgdorferi infection [3] [4]. Cardiac manifestations occur in up to 10% of patients, the most common of which is AV block (our patient had a new onset 1st degree heart block). "
    [Show abstract] [Hide abstract]
    ABSTRACT: We present a case of a 68-year-old man with a history of liver transplant and of chronic immunosuppression therapy who presented to the emergency department (ED) for fevers and worsening fatigue for two days. On further investigation, the patient was found to have a new first-degree heart block on his electrocardiograph. Coupled with the history of a recent tick bite, the patient was diagnosed with vector-borne carditis. Although the patient's titers for various vectors remained negative, due to a long history of immunosuppression, he was treated for Lyme disease and his heart block completely resolved with antibiotic treatment. We describe details of the case as well as discuss the impacts of immunosuppression on vector-borne disease. Immunosuppressed patients represent a special population and can present with chief complaints made even more complicated by their medical history, and this case illustrates the importance of being mindful of how immunosuppression can affect a patient's presentation. As the efficacy of antirejection medications improved, the ED may see an increasing number of patients with solid organ transplants. A greater understanding of this special patient population is key to formulating optimal treatment plans.
    08/2013; 2013:380734. DOI:10.1155/2013/380734
  • Source
    • "US Centers for Disease Control and Prevention (CDC) recommends a two step testing process for the diagnosis of Lyme disease, with the first step being the enzyme linked immunosorbent assay test (ELISA), which is highly sensitive, followed by Western blot to confirm the positive titres.7,9,10 Diffuse, intense uptake on gallium myocardial scan is suggestive of myocarditis.11,12 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Lyme disease is caused by bacterial spirochete Borrelia burgdorferi and is transmitted by Ixodes scapularis and Ixodes pacificus ticks, which get infected while feeding on the reservoir host of the bacteria.1 About 248,074 cases of Lyme disease were reported by the US Centers for Disease Control and Prevention from 1992-2006.2 Over 95% of these cases are reported from the Northeastern and upper Midwestern United States.3 Carditis is usually a clinical manifestation/complication of Lyme disease and is seen in approximately 5% of untreated cases.4. A 32-year-old male Hispanic from Chile presented with brief episodes of loss of consciousness and awareness of irregular heart beat, and denied any history of tick bite. The patient was found to have a heart rate of 40 beats per minute and fluctuating variable atrioventricular blocks. A transvenous pacemaker was placed with good capture. The diagnosis was made with serological testing and gallium scanning. Treatment with antibiotics and continuous cardiac monitoring resulted in remarkable symptomatic improvement of the patient. Absence of history or evidence of tick bite must not rule out the possibility of Lyme carditis in a patient with a transient heart block. Prompt recognition of this reversible cause of heart block is essential for avoiding implantation of an unnecessary, permanent pacemaker.
    International Medical Case Reports Journal 07/2010; 3(1):71-6.
  • Source
    • "Preventive strategies for Lyme disease are poorly developed and early diagnosis remains difficult (Earnhart and Marconi, 2008). If not promptly diagnosed and treated, serious sequelae can develop (Fish et al., 2008; Halperin, 2008; Puius and Kalish, 2008; Steere, 2001). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Borrelia burgdorferi outer surface protein C (ospC) is required for the establishment of infection in mammals. However, its precise function remains controversial. The biologically active form of OspC appears to be a homodimer. Alpha helix 1 and 1' of the apposing monomers form a solvent-accessible pocket at the dimeric interface that presents a putative ligand-binding domain (LBD1). Here we employ site-directed and allelic-exchange mutagenesis to test the hypothesis that LBD1 is a determinant of OspC function in the mammalian environment. Substitution of residues K60, E61 and E63 which line LBD1 resulted in the loss of infectivity or influenced dissemination. Analyses of the corresponding recombinant proteins demonstrated that the loss of function was not due to structural perturbation, impaired dimer formation or the loss of plasminogen binding. This study is the first to assess the involvement of individual residues and domains of OspC in its in vivo function. The data support the hypothesis that OspC interacts with a mammalian derived ligand that is critical for survival during early infection. These results shed new light on the structure-functions relationships of OspC and challenge existing hypotheses regarding OspC function in mammals.
    Molecular Microbiology 02/2010; 76(2):393-408. DOI:10.1111/j.1365-2958.2010.07103.x · 4.42 Impact Factor
Show more


14 Reads
Available from